Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and <i>in silico</i> insights-Reference-Cited by-同舟云学术

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights

Published:2023-07-20 Issue:1 Volume:38 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Hamdi Abdelrahman¹^ORCID,Yaseen Muhammad²^ORCID,Ewes Wafaa A.¹^ORCID,Bhat Mashooq Ahmad³^ORCID,Ziedan Noha I.⁴^ORCID,El-Shafey Hamed W.¹^ORCID,Mohamed Ahmed A. B.⁵^ORCID,Elnagar Mohamed R.⁶⁷^ORCID,Haikal Abdullah⁸^ORCID,Othman Dina I. A.¹,Elgazar Abdullah A.⁹^ORCID,Abusabaa Ahmed H. A.¹⁰^ORCID,Abdelrahman Kamal S.¹¹^ORCID,Soltan Osama M.¹¹^ORCID,Elbadawi Mostafa M.¹²^ORCID

Affiliation:

1. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

2. Institute of Chemical Sciences, University of Swat, Swat, Pakistan

3. Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

4. Department of physical, mathematical and Engineering science, Faculty of science, Business and Enterprise, University of Chester, Chester, UK

5. Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

6. Pharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

7. Department of Pharmacology, College of Pharmacy, The Islamic University, Najaf, Iraq

8. Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

9. Department of Pharmacognosy, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

10. Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt

11. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt

12. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

Funder

King Saud University, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2231170

Reference64 articles.

1. Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics

2. A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity

3. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases

4. Drug-Induced Hypoglycemia: A Review of 1418 Cases

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of non-acidic 4-methylbenzenesulfonate-based aldose reductase inhibitors; Design, Synthesis, Biological evaluation and in-silicostudies;Bioorganic Chemistry;2024-10

2. Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements;ChemistryOpen;2024-09-09

3. Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study;Molecules;2024-07-04

4. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study;Bioorganic Chemistry;2024-07

5. In-silico Binding, Stability, Pharmacokinetics, and Toxicity Studies on Natural (-)-ambrox Metabolites as Binding Ligands to Luminal B and Triple-negative/basal-like Proteins for Breast Cancer Therapy;Letters in Drug Design & Discovery;2024-07